Related by context. All words. (Click for frequent words.) 71 HIV protease inhibitor 64 HCV protease inhibitor 61 HCV polymerase 60 apricitabine ATC 60 HCV polymerase inhibitor 60 developing TB4 60 HIV integrase inhibitor 59 inflammatory autoimmune diseases 59 MEK inhibitor 59 ALN PCS 58 polymerase inhibitors 58 DNA RNA Medicines 58 rheumatoid arthritis thrombocytopenia 58 non nucleoside HCV 58 epothilone 58 Cetrorelix 58 staphylococcal vaccines 58 recombinant biopharmaceutical 58 oral PTH 58 targeted radiotherapeutic 58 RGB # 57 Onalta ™ 57 therapeutic monoclonal antibody 57 TRAIL receptor antibodies 57 XL# XL# 57 topical anti infective 57 MKC# MKC# PP 57 Kosan dependence 57 Hepatitis C Virus HCV 57 molecular imaging radiopharmaceutical 57 Avian Transgenic Technology 57 Protexia ® 57 oral prodrug 57 oncolytic virus therapies 57 oral dihydropyrimidine dehydrogenase DPD 57 multi kinase inhibitor 57 IMA# 57 progressive metastatic prostate 57 MKC# MT 56 Archexin 56 DPX Survivac 56 oral picoplatin 56 PDE4 inhibitor 56 immunotherapeutic vaccine 56 Panzem R 56 small molecule glucokinase 56 orally administered inhibitor 56 glucokinase activator 56 therapeutic peptide 56 PDE7 56 Angiocept 56 XL# anticancer compounds 56 anti CD3 monoclonal 56 liposomal formulation 56 HCV nucleoside polymerase inhibitors 56 oral proteasome inhibitor 55 Alnylam #x# 55 selective immunoproteasome inhibitor 55 Vaccinex 55 MVA BN R 55 gastro intestinal inflammation 55 investigational hepatitis B 55 novel therapeutic antibodies 55 MAXY G# 55 TKB# 55 ONCONASE R 55 CCR5 antagonists 55 HIV maturation inhibition 55 ZFP Therapeutics 55 InterfeRx TM 55 HepeX B 55 PHX# 55 CCR9 antagonist 55 evaluating picoplatin 55 EGEN 55 cathepsin K inhibitor 55 Enhanze 55 Aganocide 55 thiazolides 55 romazarit 55 R#/MEM # 54 Chimigen TM 54 tiapamil 54 HepDirect 54 CCR5 antagonist 54 Aurora kinase inhibitor 54 NPC 1C 54 Isis antisense 54 anticancer compound 54 chimeric monoclonal antibody 54 HIV integrase inhibitors 54 TKM ApoB 54 ImmunoGen TAP technology 54 PI3K/Akt pathway inhibitor 54 Pradefovir 54 Nanobody 54 novel RNAi therapeutics 54 therapeutic monoclonal antibodies 54 siRNA therapeutics 54 IMC #B 54 XL# XL# XL# XL# 54 anthrax monoclonal antibody 54 IMiDs R 54 Nanobody R 54 LentiVector technology 54 Factor VIIa 54 PNP inhibitor 54 vaccine adjuvant 54 ALN TTR 54 Ophthotech 54 Solazed TM 54 Anticalin 54 drug conjugate 54 alvespimycin 54 nucleoside tide analogs 54 Euronext Amsterdam GLPGA 54 CRACM 54 ARRY # 54 Proellex TM 54 drug pipeline TAFA# 54 polymerase inhibitor 54 ImQuest 54 using ImmunoGen TAP 54 Adnectin 54 IAP inhibitors 54 humanized monoclonal antibody 54 LHRH antagonist 54 molecular chaperone regulation 54 EP #R 53 HuLuc# 53 rNAPc2 53 preclinical compounds 53 MEK inhibitors 53 virus HCV protease inhibitor 53 Nanobody ® 53 vaccine GRNVAC1 53 forodesine 53 investigational oral inhibitor 53 forodesine hydrochloride 53 Quark Biotech 53 Curaxin 53 JAK1 53 Merck OSI Pharmaceuticals 53 THR beta agonist 53 ATL# [002] 53 deforolimus 53 CYT# vascular disrupting 53 ospemifene 53 Preclinical studies suggest 53 Vicriviroc 53 Personalized Immunotherapy 53 cancer immunotherapy 53 outlicensing 53 GLPG# 53 next generation URAT1 53 PEG SN# 53 Onalta 53 systemic RNAi therapeutic 53 TRO# 53 Surfaxin LS 53 Panzem 53 anticancer compounds 53 MGCD# [001] 53 RELOVAIR ™ 53 ASONEP 53 HTS assay 53 nucleoside analog 53 prophylactic vaccines 53 histone deacetylase HDAC inhibitors 53 PEGylated interferon 53 ALN VSP 53 delta isoform 53 CYT# potent vascular disrupting 53 immatics 53 Adenosine Therapeutics 53 rxRNA 53 tezampanel NGX# 53 Elvitegravir 53 histone deacetylase HDAC 53 proteasome inhibitor 52 Tumour Vascular Disrupting Agent 52 CCX# 52 Locked Nucleic Acid 52 Xcellerex FlexFactory 52 prophylactic vaccine 52 radiation sensitizer 52 lintuzumab SGN 52 flu mAb 52 drug conjugate ADC 52 selective androgen receptor modulators 52 CMV vaccine 52 humanized monoclonal antibodies 52 intranasal formulation 52 PORxin TM 52 seliciclib CYC# 52 JAK inhibitor 52 OMP #R# 52 Zolinza 52 Azedra 52 Galenea 52 biotherapeutic drugs 52 ASG 5ME 52 RNAi therapeutic targeting 52 oncolytic 52 siRNA therapeutic 52 HCV polymerase inhibitors 52 IND enabling 52 Crucell PER.C6 ® 52 diabetes irritable bowel 52 CCR5 inhibitor 52 leading oral taxane 52 integrase inhibitor 52 ketolide antibiotic 52 Pancreate 52 Tesetaxel 52 MKC# 52 adrenergic regulation 52 FOLOTYN ® 52 selective androgen receptor modulator 52 include SOD superoxide 52 AtuRNAi 52 Prodarsan R 52 TLR9 agonist 52 Spiegelmer ® 52 include VALSTAR TM 52 Allovectin 7 52 TBC# 52 mertansine 52 Valortim TM 52 Elagolix 52 Selective Electrochemical Tumor Ablation 52 volociximab 52 InterfeRx 52 anti botulism antibody 52 YONDELIS 52 UltiMAb ® 52 5 HT6 52 ZK EPO 52 Galderma SA 52 radiotherapeutic 52 elotuzumab 52 Homspera TM 52 Virosome Biologicals 52 nicotinic alpha 7 52 including eniluracil ADH 52 Guanilib 52 Bicifadine 52 AEG# 52 XmAb ® 52 Roche SWX ROG 52 Novosom 52 metaglidasen 52 synthetic retinoid 52 Onconase 52 SinuNase ™ 52 Intarcia 52 HIV AIDS neuropathic pain 52 CORT # 52 DAVANAT R 52 Innovive Pharmaceuticals 51 vaccine adjuvants 51 Argatroban 51 CRTH2 51 Exherin 51 GeoVax AIDS vaccine 51 histone methyltransferases HMTs 51 PhaseBio 51 MorphoSys proprietary 51 candidate ATHX 51 GVAX cancer 51 recombinant subunit vaccine 51 Phase IIb clinical trials 51 candidate CRLX# 51 tubulin inhibitor 51 oral antiviral 51 Capsulution 51 Aquinox 51 Receptors GPCRs 51 HCD# [002] 51 Proteo 51 Zacharon 51 Solazed 51 Sangamo ZFP technology 51 pan HDAC inhibitor 51 MicroDose 51 oral ghrelin agonist 51 immunological diseases 51 Stapled Peptide 51 motexafin gadolinium Injection 51 Marqibo TM 51 P#X# antagonist 51 Neo Kidney Augment ™ 51 Intravenous CP 51 MediVas 51 celgosivir 51 acne impetigo 51 Troxatyl 51 chemosensitizer 51 ViroChem 51 Receives Milestone Payment 51 proprietary MSCRAMM ® 51 PRT# 51 JAK2 inhibitor 51 LymphoStat B TM 51 novel anticancer 51 Ramoplanin 51 MOR# 51 Veronate 51 Fleximer 51 herpetic keratitis 51 AlphaVax 51 sodium glucose transporter 51 EHT AGN 51 HuMax TAC 51 delta opioid receptor 51 Telatinib 51 Bavarian Nordic patented 51 selectively modulate 51 nucleoside tide 51 TELINTRA R 51 ErbB3 51 Anaphore 51 Onco TCS 51 NTDDS 51 epigenetic therapies 51 BCR ABL inhibitors 51 CD# CEA 51 fusion inhibitor 51 selectively inhibit replication 51 HCV protease inhibitors 51 purinergic receptors P#X# 51 Cobalamin 51 ALN RSV program 51 Bellicum 51 HCV antiviral 51 myasthenia gravis Huntington 51 DepoVax TM 51 Antibody Drug Conjugate 51 sapropterin dihydrochloride 51 Potelligent Technology 51 inhaled formulation 51 Maxy G# 51 stable nucleic acid 51 ABthrax TM raxibacumab 51 EVIZON TM squalamine lactate 51 Sangamo ZFP TF 51 AN# novel 51 Albugon 51 novel immunomodulatory 51 investigational monoclonal antibody 51 Alnara Pharmaceuticals 51 novel antiviral therapeutics 51 Exelixis XL# 51 Curaxins 51 small molecule tyrosine 51 HuCAL 51 OGeS 51 IMiDs ® 51 GPR# agonist 51 histone deacetylase inhibitor 51 Xanafide 51 OvaRex R 51 CEQ# 51 LGLS 51 OMJPI 51 VaxImmune 51 biomarker discovery 51 RNA therapeutics 51 Solzira ™ 51 GV# [001] 50 novel immunotherapies 50 personalized immunotherapy 50 outlicensed 50 hepatitis C protease inhibitor 50 Crucell genetically engineered 50 tesetaxel 50 XmAb 50 Litx 50 Plasma Converter TM 50 commercialize OncoGenex lead 50 MAXY VII 50 regorafenib 50 Exelixis compounds 50 Daclizumab 50 VIBATIV ™ 50 Ceflatonin R 50 Enanta 50 cancer immunotherapies 50 Zemiva TM 50 Tyzeka Sebivo 50 KSP inhibitor 50 Targeted Chemotherapy 50 Alferon LDO 50 Neutrolin ® 50 pradefovir 50 Mersana 50 aldehyde dehydrogenase ALDH2 deficiency 50 oncolytic viruses 50 Trofex 50 Phase 2a clinical trials 50 Squalamine 50 Campto 50 XOMA 3AB 50 kinase inhibitor 50 buccal delivery 50 CobaCyte 50 Endotis 50 romidepsin novel 50 HepDirect R 50 L BLP# 50 Tolerx 50 Scil Proteins 50 Inotek Pharmaceuticals Corporation 50 PGL# 50 DOS# 50 VivaGel TM 50 5 HT6 antagonist 50 Aganocide ® 50 dacetuzumab 50 nitric oxide donating prostaglandin 50 using BioSante patented 50 antibiotic resistant bacterial infections 50 Stimuvax R 50 vosaroxin 50 Micromet proprietary BiTE 50 Tyrima 50 orally bioavailable 50 ViiV Healthcare 50 PREOS R 50 calcitonin manufacturing 50 hepatitis C polymerase inhibitor 50 PF # [002] 50 Micromet BiTE 50 Charlesson 50 Alocrest 50 Prednisporin 50 Fleximer R 50 Sym# 50 Ridaforolimus 50 ridaforolimus 50 PER.C6 50 Aurexis 50 EndoTAG TM 50 SMARTICLES ® 50 AFFiRiS 50 NOX E# 50 humanized antibody 50 predictive biomarkers 50 Sopherion 50 DU #b 50 biodefense pathogens 50 patented NanoStat ™ 50 OncoVEX GM CSF 50 preclinical toxicology 50 PDE4 modulators 50 Cathepsin S 50 StromaCel Inc. 50 GED aPC 50 ELND-#/AZD-# 50 Fc fusion protein 50 Celator 50 PER.C6 r 50 StaphVAX R 50 Vegenics 50 Insegia 50 RNAi therapeutic 50 Affilin ® 50 Lenocta 50 Epitomics 50 Medidur ™ FA 50 IDRI 50 danoprevir 50 antigen sparing 50 Nektar proprietary 50 Viral Immunotherapy platform 50 NEUGENE R 50 small molecule PEGylation 50 lipid nanoparticle 50 Ligand proprietary 50 Minapharm 50 AskBio 50 developing Zerenex ferric 50 BioWa 50 Aegera Therapeutics 50 anti secretory 50 XmAb# 50 NXL# 50 Diamyd ® 50 IMPDH inhibitor 50 MAXY alpha 50 Genocea 50 HGS# 50 ALN RSV# 50 HuCAL antibodies 50 vaccines oncolytic virus 50 aminocandin 50 ASONEP TM 50 Aganocide TM 50 HCV nucleotide polymerase inhibitor 50 GLP toxicology studies 50 EndoTAG TM -1 50 Intraject 50 Protexia R 50 renin inhibitor 50 JAK3 inhibitor 50 BioFocus 50 demethylating agents 50 DeveloGen 50 immunotherapeutic approaches 50 Shigamabs ® 50 UltiMAb 50 OHR/AVR# 50 HuCAL PLATINUM 50 UVIDEM 49 PEGylation technology 49 Panzem R NCD 49 Hybridon 49 RhuDex ® 49 NIH NIAID 49 IND submission 49 Pertuzumab 49 TLR8 agonist 49 Chiral Quest 49 Dapagliflozin 49 Uvidem 49 Xencor 49 unpartnered 49 proprietary bioresorbable polymer 49 Lixivaptan 49 isoform selective 49 otelixizumab 49 Mpex 49 SAR# [002] 49 Aegera 49 BiTE 49 commercialize becocalcidiol patented 49 SNT MC# 49 HDL Selective Delipidation 49 Cerimon 49 PNT# 49 Juvaris 49 Hsp# inhibition 49 intranasal insulin product 49 Scancell 49 Xcytrin R 49 PsychoGenics 49 RNA antagonists 49 Hedgehog agonist 49 Enhanze Technology 49 Aplidin 49 adrenal steroid hormones 49 GlycArt 49 OAB overactive bladder 49 HepDirect prodrug 49 atacicept 49 budesonide MMX Phase III 49 Ostabolin C TM 49 virosome 49 RiVax ™ 49 MDV# 49 HGS ETR1 49 Dyax phage display 49 NovaBay Aganocide compounds 49 Tarmogen 49 Regulus Therapeutics 49 Catalyst Biosciences 49 ProLindac TM 49 AVP #D# 49 enzastaurin 49 Tibotec BVBA 49 Syntonix 49 Eg5 kinesin spindle 49 HSP# inhibitor 49 immunotherapeutics 49 Icatibant 49 sapacitabine CYC# 49 Hsp# inhibitor 49 AQUA ® 49 HyperAcute 49 IMC #F# 49 alkylating agent 49 Lupuzor 49 Aviptadil 49 SansRosa 49 cardiovascular disease neurodegenerative diseases 49 Cellerant 49 therapeutic antibody 49 ALN TTR# 49 HuCAL antibody 49 Immuron 49 anticancer therapeutics 49 theranostic 49 CDP# 49 platforms GVAX 49 tubulin inhibitors 49 Bioral Amphotericin B 49 Synavive ™ 49 A3 adenosine receptor 49 EnVivo Pharmaceuticals 49 Inotek 49 clinically validated targets 49 molecular imaging radiopharmaceuticals 49 targeting PCSK9 49 Cethromycin 49 blood clot dissolver 49 JAK3 49 preclinical 49 BioSeek 49 CureDM 49 elvucitabine 49 Delafloxacin 49 peripherally acting 49 AVEO integrates proprietary 49 ENMD # 49 PanGenetics 49 SparVax ™ 49 QuatRx 49 faropenem 49 recombinant plasma 49 allosteric modulator 49 Sirona Biochem 49 BXT # 49 Hedgehog antagonist 49 Hsp# inhibitors 49 Salmedix 49 tolevamer 49 Neurimmune 49 unique PER.C6 49 ZOLINZA 49 OvaRex 49 thymidylate synthase 49 Anthim 49 systemic RNAi 49 Avila Therapeutics 49 AKT inhibitor 49 Biotica 49 DepoVax ™ 49 Epothilones 49 fostamatinib 49 Lenocta TM sodium stibogluconate 49 Nasdaq RXII 49 PDE# inhibitors 49 anti fibrotic 49 ALS #-# 49 BioSante LibiGel Phase III 49 Panflu 49 SARMs 49 Prima BioMed 49 NicVAX 49 RIGScan CR 49 EpiTherapeutics 48 recombinant protective 48 CD# antibody [001] 48 TOCOSOL Paclitaxel 48 Thiovir 48 Amira Pharmaceuticals 48 Receptos 48 URG# 48 Metallophile ™ Technology 48 Loramyc ™ 48 Hyaluron 48 OMP #M# 48 TMC# [002] 48 Spiegelmer 48 ALN HTT 48 obatoclax 48 Trofex TM 48 Enzo Therapeutics 48 OMAPRO ™ 48 Presents Preclinical 48 Pharmacopeia Nasdaq PCOP 48 Shigamabs R 48 immunomodulating 48 Phase 2b clinical trials 48 selective angiogenic kinase inhibitor 48 Chipscreen 48 investigational atypical antipsychotic 48 CINQUIL 48 antisense inhibitors 48 CINOD 48 Blinatumomab 48 mTOR inhibitor 48 Transfluor 48 OncoMed 48 Azedra TM 48 DsiRNA 48 GSK '# 48 Protectan CBLB# 48 OvaRex ® MAb 48 Ibis T# Biosensor System 48 dextofisopam 48 PSN# [001] 48 Tekmira lipid nanoparticle 48 NS5A 48 prostone 48 TLR Therapeutics 48 Hemopurifier ® 48 humanized antibodies 48 developed preclinically 48 neuraminidase inhibitor 48 panitumumab Vectibix 48 HyACT 48 Melior Discovery 48 Tobira Therapeutics 48 GAP #B# 48 Viamet 48 Cenix BioScience 48 Posiphen TM 48 biodefense vaccines 48 orally bioavailable mimics 48 Antisense 48 ovarian cancer chronic hepatitis 48 monoclonal antibody therapeutics 48 RNAi therapeutic targeting PCSK9 48 SERMs 48 commercialize Aganocides 48 NEUMUNE 48 mGluR4 PAM 48 XL# XL# XL# 48 PSN# [002] 48 nucleotide analog polymerase inhibitor 48 BioNumerik 48 Zor Pharmaceuticals 48 INCB# [001] 48 BCX# 48 peptide therapeutics 48 selective estrogen receptor modulator 48 cardio renal 48 Triapine 48 betrixaban 48 DPP4 inhibitor 48 ARIKACE ™ 48 Restanza 48 AdVac 48 tranilast 48 phase IIb clinical 48 Epizyme 48 chemopreventive agent 48 Agenerase 48 Zalbin 48 ALZA Corporation 48 PANVAC VF 48 Genocea Biosciences 48 relapsed leukemia 48 TOCOSOL 48 peptide synthesis 48 Zoraxel TM 48 Nycomed GmbH 48 SGLT inhibitors 48 TRIOLEX ™ 48 Mipomersen 48 Neogenix 48 protein kinase inhibitor 48 KuDOS 48 Lexicon Genetics 48 GelSite 48 DAS# [001] 48 bardoxolone 48 KaloBios 48 EyeGate Pharma 48 Viread tenofovir disoproxil fumarate 48 MorphoSys antibody 48 antimitotic 48 PI3K inhibitor 48 midstage clinical 48 OPi 48 NKT Therapeutics 48 Ebola SNALP 48 Oasmia 48 Intellikine 48 Oral NKTR 48 telaprevir VX 48 novel anti infective 48 plasmid DNA vaccine 48 NMDA antagonist 48 Jubilant Biosys 48 Anacor 48 SparVax TM 48 MCSP respectively 48 highly selective endothelin 48 Pepscan 48 monoclonal antibody mAb 48 LNP formulations 48 davalintide 48 Pimavanserin 48 maturation inhibition 48 shRNA libraries 48 selective kinase inhibitor 48 Crucell PER.C6 48 Nasdaq CGEN 48 oncology therapeutics 48 VentiRx 48 teplizumab 48 KNS # 48 Myocet 48 Juvantia 48 thrombin inhibiting aptamer 48 Graffinity 48 NEUGENE 48 Vitamin D analogue 48 immunotherapeutic 48 renin inhibitors 48 diagnostic molecular imaging 48 Trophos 48 Factor Xa inhibitor 48 oral talactoferrin 48 entinostat 48 Nektar pulmonary 48 BioGeneriX 48 Santaris 48 candidate custirsen 48 commercial bioproduction 48 SoluBest 48 estrogen receptor antagonist 47 Roche OTC RHHBY 47 Phase IIa trials 47 ganetespib 47 * olmesartan medoxomil 47 Immunex Corporation 47 nucleotide analog 47 Diamyd R 47 oral transmucosal 47 cGMP manufacture 47 OncoVEX 47 Aurograb 47 Oncolys 47 immunomodulator 47 Regado 47 vilazodone 47 pharmacological chaperone 47 Aerosurf 47 miRNA therapeutics 47 oral salmon calcitonin 47 Piramed 47 selective S#P# receptor agonist 47 NNRs 47 gefitinib Iressa 47 ChemDiv 47 iPSC technology 47 Medical Countermeasure 47 GlaxoSmithKline Biologicals GSK 47 Olaparib 47 LHRH antagonists 47 pafuramidine 47 SYGNIS 47 compound KOS 47 RIGScan 47 mucosal vaccines 47 Pervasis 47 ErbB3 HER3 47 FoldRx Pharmaceuticals Inc. 47 OLIGON technology 47 Microbix Biosystems 47 registrational 47 Therion Biologics Corporation 47 hypoxia activated prodrug 47 HuMax 47 Bruton tyrosine kinase Btk 47 JAK inhibitors 47 torezolid 47 Urocidin 47 CDAD Clostridium difficile 47 BioGlue R 47 Idera Pharmaceuticals 47 injectable bulking agent 47 HQK 47 VitiGam 47 Cempra 47 mGluR2 NAM 47 Davanat 47 particle VLP 47 Numoda 47 Valortim 47 biosurgical 47 Tarvacin Anti Cancer 47 Behcet uveitis 47 VelocImmune 47 antisense drug 47 EOquin 47 sodium glucose cotransporter 47 Quark Biotech Inc. 47 Chimigen 47 antiviral therapeutics 47 antisense drugs 47 SECTA therapy 47 biodefence 47 IGN# 47 Portola Pharmaceuticals 47 voreloxin 47 Qualified Therapeutic Discovery 47 Lycera 47 apply Enhanze technology 47 Inpharmatica 47 Kyowa Hakko Kirin 47 highly selective adenosine 47 nucleoside analogues 47 DXL# 47 peg EPO 47 Therion Biologics 47 Cloretazine 47 EvaMist TM 47 anthrax tuberculosis typhoid 47 PharmaNova 47 Fovea Pharmaceuticals 47 RNAi gene silencing 47 MAbs 47 Arrow Therapeutics 47 Nasdaq LEXG 47 compound AEOL # 47 Profectus BioSciences 47 predictive toxicology 47 targets EpCAM expressing 47 Oxxon 47 immunology oncology 47 anti amnesic 47 combinatorial chemistry 47 ddRNAi 47 ARIUS 47 AERx iDMS 47 inhibit replication 47 commercializing therapeutic 47 GEMS TM 47 methylnaltrexone 47 Zenyaku Kogyo 47 ABILIFY ® 47 commercialize lorcaserin 47 Zybrestat 47 platinum chemotherapeutic 47 POTELLIGENT R 47 Alferon N 47 Bayhill Therapeutics 47 CellCentric 47 AzaSite Plus 47 lumiliximab 47 Novartis NVS Snapshot Report 47 Virium 47 RNAi therapeutic platform 47 Epigenomics proprietary 47 ularitide 47 midstage studies 47 Caprion 47 Genetronics 47 clinical trials Archexin 47 Marcadia 47 Supernus Pharmaceuticals 47 Prodarsan ® 47 biobetter 47 anti CD# antibodies 47 kinase inhibitors 47 virology immunology 47 adenovector 47 FoldRx 47 HCV nucleoside 47 S#P# 47 Toraymyxin TM 47 Ibis Biosciences 47 stem cell therapeutics 47 ELACYT 47 YONDELIS R 47 TLR agonists 47 TPI ASM8 47 biomarker identification 47 Coley Pharmaceutical Group 47 Anticalin R 47 generation PNP inhibitor 47 orally dosed 47 RiVax 47 IMC A# 47 castrate resistant prostate cancer 47 rPA anthrax vaccine 47 TolerRx 47 SAR# [004] 47 Corixa Corporation 47 Rotarix ® 47 PEG Interferon lambda 47 staphylococcal vaccine 47 AnGes 47 Evoltra ® 47 registrational trials 47 Chinipas 47 LEX System 47 formed Alnylam Biotherapeutics 47 NASDAQ ALNY 47 Gastrotech 47 Lentiviral vector 47 Sequella 47 Aeolus Pharmaceuticals 47 AVAX AC Vaccine 47 Kosan motilin agonist 47 biologic therapeutics 47 elinogrel 47 anthrax botulism tuberculosis typhoid 47 pandemic influenza vaccine 47 registrational trial 47 Radezolid 47 Kapa Biosystems 47 topical antifungal 47 HEPLISAV ™ 47 triphendiol